Gmax Biopharm LLC, based in Hangzhou, China, specializes in the research, development, and manufacturing of biopharmaceutical products. The company focuses on innovative therapies and solutions aimed at addressing various health challenges. With a commitment to advancing healthcare, Gmax Biopharm leverages cutting-edge technology and scientific expertise to enhance the efficacy and safety of its offerings. The organization is dedicated to improving patient outcomes through its robust pipeline of biopharmaceutical innovations.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

10 Patents

#77 in Hangzhou

#2,795 in China

#55,986 in the World

Hangzhou, China

Gmax Biopharm LLC

Forward Citations = 1

14 inventors:

Hua Zhang (10 out of 15 patents)

Cheng Zhang (10 out of 15 patents)

Shuqian Jing (10 out of 11 patents)

4. Xiaofeng Wang (9 out of 12 patents)

5. Chenjiang Yao (9 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gmax Biopharm LLC. Retrieved from https://idiyas.com/company/gmax-biopharm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]